778 related articles for article (PubMed ID: 22249462)
1. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.
Gertz B; Wong M; Martin LJ
J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462
[TBL] [Abstract][Full Text] [Related]
2. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
3. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
Turner BJ; Parkinson NJ; Davies KE; Talbot K
Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
Turner BJ; Alfazema N; Sheean RK; Sleigh JN; Davies KE; Horne MK; Talbot K
Neurobiol Aging; 2014 Apr; 35(4):906-15. PubMed ID: 24210254
[TBL] [Abstract][Full Text] [Related]
5. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
Kariya S; Re DB; Jacquier A; Nelson K; Przedborski S; Monani UR
Hum Mol Genet; 2012 Aug; 21(15):3421-34. PubMed ID: 22581780
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
7. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.
Turner BJ; Atkin JD; Farg MA; Zang DW; Rembach A; Lopes EC; Patch JD; Hill AF; Cheema SS
J Neurosci; 2005 Jan; 25(1):108-17. PubMed ID: 15634772
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice.
Xu G; Ayers JI; Roberts BL; Brown H; Fromholt S; Green C; Borchelt DR
Hum Mol Genet; 2015 Feb; 24(4):1019-35. PubMed ID: 25305079
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic.
Martin LJ; Adams DA; Niedzwiecki MV; Wong M
Cells; 2022 Oct; 11(21):. PubMed ID: 36359844
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.
Prudencio M; Durazo A; Whitelegge JP; Borchelt DR
J Neurochem; 2009 Feb; 108(4):1009-18. PubMed ID: 19077113
[TBL] [Abstract][Full Text] [Related]
11. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis.
Ekhtiari Bidhendi E; Bergh J; Zetterström P; Forsberg K; Pakkenberg B; Andersen PM; Marklund SL; Brännström T
Acta Neuropathol; 2018 Dec; 136(6):939-953. PubMed ID: 30284034
[TBL] [Abstract][Full Text] [Related]
12. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
14. NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1
Yang B; Pan J; Zhang XN; Wang H; He L; Rong X; Li X; Peng Y
Neurobiol Dis; 2023 Aug; 184():106210. PubMed ID: 37352984
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
16. Decreased glutathione levels cause overt motor neuron degeneration in hSOD1
Killoy KM; Harlan BA; Pehar M; Helke KL; Johnson JA; Vargas MR
Exp Neurol; 2018 Apr; 302():129-135. PubMed ID: 29307609
[TBL] [Abstract][Full Text] [Related]
17. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
18. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
19. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
[TBL] [Abstract][Full Text] [Related]
20. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
